Encompass Health (EHC) vs. Its Competitors Head to Head Contrast

Encompass Health (NYSE: EHC) is one of 44 public companies in the “Healthcare Facilities & Services” industry, but how does it contrast to its rivals? We will compare Encompass Health to related companies based on the strength of its dividends, valuation, earnings, profitability, risk, institutional ownership and analyst recommendations.


Encompass Health pays an annual dividend of $1.00 per share and has a dividend yield of 1.7%. Encompass Health pays out 37.3% of its earnings in the form of a dividend. As a group, “Healthcare Facilities & Services” companies pay a dividend yield of 0.9% and pay out 21.9% of their earnings in the form of a dividend.

Earnings and Valuation

This table compares Encompass Health and its rivals top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Encompass Health $3.97 billion $256.30 million 21.78
Encompass Health Competitors $6.46 billion $160.90 million 243.39

Encompass Health’s rivals have higher revenue, but lower earnings than Encompass Health. Encompass Health is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

91.4% of Encompass Health shares are held by institutional investors. Comparatively, 74.6% of shares of all “Healthcare Facilities & Services” companies are held by institutional investors. 1.6% of Encompass Health shares are held by insiders. Comparatively, 13.6% of shares of all “Healthcare Facilities & Services” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.


This table compares Encompass Health and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Encompass Health 6.45% 20.59% 5.43%
Encompass Health Competitors 0.62% 1.46% 2.41%

Volatility and Risk

Encompass Health has a beta of 0.48, suggesting that its stock price is 52% less volatile than the S&P 500. Comparatively, Encompass Health’s rivals have a beta of 0.67, suggesting that their average stock price is 33% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations and price targets for Encompass Health and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Encompass Health 0 2 2 0 2.50
Encompass Health Competitors 251 1482 1947 39 2.48

Encompass Health currently has a consensus target price of $60.00, suggesting a potential upside of 2.69%. As a group, “Healthcare Facilities & Services” companies have a potential upside of 0.91%. Given Encompass Health’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Encompass Health is more favorable than its rivals.


Encompass Health beats its rivals on 8 of the 15 factors compared.

About Encompass Health

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice. It is an owner and operator of inpatient rehabilitation hospitals. It provides specialized rehabilitative treatment on both an inpatient and outpatient basis. It offers its home health and hospice services through Encompass Home Health and Hospice business (Encompass). Encompass operates home health and hospice agencies in 25 states, with concentrations in the Southeast, Oklahoma, and Texas. As of December 31, 2016, the Company operated 123 inpatient rehabilitation hospitals.

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply